This thiazolidone used clinically for the treatment of type 2 diabetes mellitus, reduced antibodies production, renal disease, and atherosclerosis in mouse models of SLE, and these beneficial effects were dependent on the induction of adiponectin, since these actions were not observed in lupus mice lacking adiponectin [10]. Here, ADIPOQ is linked to type 2 diabetes mellitus.